Literature DB >> 24948822

Pituitary incidentaloma found on O-(2-18F-fluoroethyl)-l-tyrosine PET.

Geoffrey M Currie1, Marko Trifunovic2, Hosen Kiat3, Catherine Saunders2, David Chung2, Yang-Yi Ong2, Mark Wilkinson2, Karin Witte2, John Magnussen4.   

Abstract

Although incidental pituitary findings on (18)F-FDG PET are uncommon, there are several reports published in the literature. It is believed that this is the first reporting of incidental pituitary disease found on O-(2-(18)F-fluoroethyl)-l-tyrosine ((18)F-FET) PET imaging. The case provides valuable insight into pathogenesis, diagnostic tools, and related pathology. The power of (18)F-FET in differentiating cerebral metastases and recurrence in patients who had previous surgical and radiation therapy is highlighted, and the incremental benefits over MR imaging and (18)F-FDG PET are outlined. The case represents an uncommon finding on MR imaging and (18)F-FDG PET and a rare finding on (18)F-FET PET.
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  18F-FET; PET/CT; adenoma; metastatic disease; pituitary

Mesh:

Substances:

Year:  2014        PMID: 24948822     DOI: 10.2967/jnmt.113.136291

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  3 in total

Review 1.  Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.

Authors:  Amy Yao; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2017-04-28       Impact factor: 2.104

2.  Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.

Authors:  Sven Berkmann; Michel Roethlisberger; Beat Mueller; Mirjam Christ-Crain; Luigi Mariani; Egbert Nitzsche; Freimut Juengling
Journal:  Pituitary       Date:  2021-06-21       Impact factor: 4.107

3.  Positive [18F]fluoroethyltyrosine PET/MRI in suspected recurrence of growth hormone-producing pituitary adenoma in a paediatric patient.

Authors:  Sophie E M Veldhuijzen van Zanten; Sebastian J C M M Neggers; Roelf Valkema; Frederik A Verburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-05       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.